Current role
Biotechnology · Healthcare
Board Member
2023-01-01–present
Steven Zelenkofske
Board Member
Cadrenal Therapeutics, Inc. (CVKD)Equibles does not estimate personal net worth.
Get an email with a short summary when Cadrenal Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CVKD alertsAbout Steven Zelenkofske
Steven Zelenkofske is recorded as Board Member at Cadrenal Therapeutics, Inc. (CVKD) since January 19, 2023. Cadrenal Therapeutics, Inc. reported in an 8-K filed June 29, 2026 that Steven Zelenkofske resigned as Class III member of the Board, effective June 30, 2026. Cadrenal Therapeutics, Inc. reported in an 8-K filed January 25, 2023 that Steven Zelenkofske was appointed Class III director, effective January 19, 2023. Cadrenal Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cadrenal Therapeutics, Inc. includes John P. Sharp (CFO), Matthew K. Szot (CFO), Quang X. Pham (CFO, Chief Accounting Officer and Board Member) and 7 others.
“On June 28, 2026, Steven Zelenkofske, a Class III member of the Board, notified the Company of his resignation from the Board, effective June 30, 2026.”
“Effective January 19, 2023, following the time that the Registration Statement was declared effective by the Commission, Glynn Wilson was appointed as a Class I director, John Murphy was appointed as a Class II director and Steven Zelenkofske was appointed as a Class III director.”
Affiliation history
-
Current
2023-01-19–present
-
2023-01-01–2026-06-30
Company network
Leadership on record at Cadrenal Therapeutics, Inc.
- John P. Sharp CFO
- Matthew K. Szot CFO
- Quang X. Pham CFO, Chief Accounting Officer, Board Member
- Jeffrey Cole COO
- Class I Directors Board Member
- Glynn Wilson Board Member
- John Murphy Board Member
- Lee Golden Board Member
- Lee Scott Golden, M.D. Board Member
- Robert Lisicki Board Member